News Results
There are 986,558 News Results
Nov 18, 2024
Icotrokinra (JNJ-2113), a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor, met its co-primary endpoints in patients with moderate to severe plaque psoriasis
Dec 18, 2024
-- DA-1241 Demonstrated Direct Hepatic Action in Addition to Its Glucose Lowering Effect -- Patients Treated with DA-1241 100mg Achieved Statistically Significant Reduction in ALT Levels at Weeks 4 and...
May 29, 2025
- Company to Present Eight Posters and Two Oral Presentations, Including New Analyses From ALKS 2680 Phase 1 Study -
Sep 10, 2025
WALTHAM, Mass., Sept. 10, 2025 /PRNewswire/ -- Artificial Intelligence (AI) is reshaping industries, demanding meticulous implementation strategies. At AMC Bridge, we understand that harnessing AI's power is no longer a...
Oct 7, 2025
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated with the highest dose achieving endoscopic improvement at Week 12 in the Phase...
May 29, 2017
ANDOVER, Mass., May 30, 2017 /PRNewswire/ -- Casa Systems, a worldwide leader in next-generation distributed and virtualized architectures in mobile, fixed broadband and cable access networks, today announced the launch...
Jun 2, 2017
REDWOOD CITY, Calif., June 3, 2017 /PRNewswire/ -- ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced clinical data on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated Interleukin-10) in...
Jun 13, 2017
NEW YORK, June 14, 2017 /PRNewswire/ -- New York Cruise Lines , parent company of iconic Circle Line Sightseeing Cruises, is adding a new fleet to their exemplary roster with...
Jun 21, 2017
MUNICH, June 22, 2017 /PRNewswire/ -- IBM (NYSE: IBM ) today announced sweeping advances to its data governance and data science initiatives designed to help developers and analysts tap into...
